Status:
RECRUITING
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Lead Sponsor:
Indiana University
Conditions:
Acute Chest Syndrome
Sickle Cell Disease
Eligibility:
All Genders
Up to 25 years
Phase:
NA
Brief Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Detailed Description
Acute chest syndrome (ACS) is a complication of sickle cell disease where individuals have symptoms of fever, low oxygen levels or difficulty breathing in the setting of a new lung finding on chest x-...
Eligibility Criteria
Inclusion
- Age: 0-25 years old
- Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype)
- Disposition: Hospitalized for a SCD-related complication (e.g. VOC)
Exclusion
- Patient is considered hemodynamically unstable to undergo consent and study procedures
- Already has diagnosis of ACS prior to admission to inpatient unit
- POCUS operator not available
Key Trial Info
Start Date :
April 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06880679
Start Date
April 8 2025
End Date
March 1 2026
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202